UCB - 资产





资产 更改 日
Alcon AG USD 31.1B 521M 2026-06
Almirall EUR 2.37B 29.97M 2026-06
Amarin USD 624.36M 21.4M 2026-06
argenx SE USD 10.03B 1.35B 2026-06
AstraZeneca USD 115.83B 1.82B 2026-06
Bayer EUR 107.29B 659M 2026-06
Genmab DKK 12.52B 139M 2026-06
GlaxoSmithKline GBP 61.74B 1.13B 2026-06
GRIFOLS EUR 20.09B 12M 2026-06
Hikma Pharmaceutical USD 5.67B 117M 2025-12
Lakefront Biotherapeutics EUR 3.35B 21.24M 2026-06
Lonza CHF 18.97B 164M 2025-12
Merck EUR 52.69B 383M 2026-06
Novartis USD 122.03B 3.5B 2026-06
Orion EUR 1.87B 205.5M 2026-06
Recordati EUR 5.37B 33.76M 2026-06
Roche Holding CHF 98.2B 2.5B 2026-06
Sanofi EUR 129.06B 1.04B 2026-06
UCB EUR 18.16B 971M 2025-12
Unibail Rodamco EUR 49.68B 1.23B 2025-12